BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 38688590)

  • 1. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
    Sun DW; An L; Lv GY
    World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-Dependent Changes in Albumin, NLR, PLR, and AFR are Correlated with Shorter Survival in Patients with Gastric Cancer.
    Liu C; Li X
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
    Yu W; Ye Z; Fang X; Jiang X; Jiang Y
    J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
    Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
    Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
    Kato A; Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Numata M; Sawazaki S; Tamagawa A; Cho H; Morita J; Tanabe M; Kamiya N; Tamagawa H; Otani K; Kawahara S; Oshima T; Yukawa N; Saito A; Rino Y
    Anticancer Res; 2024 Jan; 44(1):331-337. PubMed ID: 38159974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Nutrition and Inflammation Assessment Tools in Esophageal Cancer Treatment.
    Aoyama T; Kazama K; Maezawa Y; Hara K
    In Vivo; 2023; 37(1):22-35. PubMed ID: 36593006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment.
    Aoyama T; Hara K; Kazama K; Maezawa Y
    Anticancer Res; 2022 Nov; 42(11):5167-5180. PubMed ID: 36288879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
    Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Onodera A; Morita J; Hashimoto I; Ishiguro T; Endo K; Cho H; Onuma S; Fukuda M; Oshima T; Yukawa N; Rino Y
    In Vivo; 2022; 36(4):1916-1922. PubMed ID: 35738628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin/fibrinogen ratio, a predictor of chemotherapy resistance and prognostic factor for advanced gastric cancer patients following radical gastrectomy.
    Zhao G
    BMC Surg; 2022 May; 22(1):207. PubMed ID: 35643493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
    Aoyama T; Ju M; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Hashimoto I; Kano K; Hara K; Cho H; Segami K; Machida D; Nakazono M; Oshima T; Yukawa N; Rino Y
    Anticancer Res; 2022 May; 42(5):2711-2717. PubMed ID: 35489731
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.